They may help lower cardiovascular risk Both medications provide benefits for heart health in people with type 2 diabetes
The medication protocol is not prescribed for those with a BMI under 30, active eating disorders, gallbladder disease, history of substance abuse, very recent bariatric surgery, pancreatitis, thyroid cancer, or other specific exclusions
26 In the SURMOUNT-2 trial involving adults with type 2 diabetes, average weight loss over 72 weeks was approximately 13.4% (10 mg) and 15.7% (15 mg), compared to 3.3% for placebo
Most patients experience side effects within the first week of starting treatment or following a dose increase, with gastrointestinal symptoms such as nausea being particularly common
Serious side effects from Rybelsus are not common, but they can happen